Skip to content
OpenCapital
Get started

Dare Bioscience, Inc. DARE Q3 2025 earnings

Reported November 13, 2025 · After market close

Revenue$2.3KMiss by $762.7K
EPS-$0.28Beat by $0.05
Revenue estimate$765.0K
EPS estimate-$0.33

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$1.7K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$152.5KBeat by $125.5KQ4 2025$1.0MBeat by $272.2K
Q3 2025$2.3KMiss by $762.7K
Q2 2025-$21.2KMiss by $168.4KQ1 2025$25.4KMiss by $574.6KQ4 2024-$63.6KMiss by $1.1M

Diluted EPS

Q1 2026-$0.20Beat by $0.13Q4 2025-$0.02Beat by $0.22
Q3 2025-$0.28Beat by $0.05
Q2 2025-$0.45Beat by $0.10Q1 2025-$0.50Beat by $0.13Q4 2024-$0.64Beat by $0.02

Ask the moment Dare Bioscience, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Dare Bioscience, Inc. report Q3 2025 earnings?
Dare Bioscience, Inc. (DARE) reported Q3 2025 earnings on November 13, 2025 after market close.
What were Dare Bioscience, Inc.'s Q3 2025 revenue and EPS?
Dare Bioscience, Inc. reported revenue of $2.3K and eps of $-0.28 for Q3 2025.
Did Dare Bioscience, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $765.0K by $762.7K. EPS beat the consensus estimate of $-0.33 by $0.05.
How did Dare Bioscience, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 94.6% from $41.7K a year earlier and eps grew 49.1% from $-0.55.
Where can I find Dare Bioscience, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022277) and the 10-Q periodic report (0001401914-25-000050) directly on SEC EDGAR. The filing index links above go to sec.gov.